KMTS
$21.14
Kestra Medical Technologies, Ltd.
Intraday
Recent News
Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Kestra Medical Technologies Ltd (NASDAQ:KMTS) is set to release its Q3 2026 earnings on Mar 17, 2026. The consensus estimate for Q3 2026 revenue is $22.86 million, and the earnings are expected to come in at -$0.60 per share.
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value
Key Insights Kestra Medical Technologies' significant private equity firms ownership suggests that the key decisions...
Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ...
Kestra Medical Technologies Ltd (KMTS) reports a 53% revenue increase and strategic growth initiatives, despite a widening net loss in Q2 2026.
Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback
Kestra Medical Technologies (KMTS) has pulled back over the past week and month, even after a strong run in the past 3 months. This makes the recent move worth unpacking. See our latest analysis for Kestra Medical Technologies. Zooming out, the stock’s 90 day share price return of 34.77 percent and year to date share price return of 10.21 percent suggest longer term momentum is still intact, despite the latest pullback to 24.07 dollars and recent volatility. If Kestra’s move has you thinking...
Kestra Medical Technologies (KMTS): Assessing Valuation After Recent Surge in Share Price
Kestra Medical Technologies (KMTS) stock has been catching some attention after a stretch of strong growth, with shares rising over 31% in the past month and nearly 58% over the past 3 months. Investors are now considering what factors could drive momentum next. See our latest analysis for Kestra Medical Technologies. The recent rally stands out even more in the context of Kestra Medical Technologies' steady 2024 performance. A 1-month share price return of 31.45% has built on longer-term...